Lanean...
Glycogen Synthase Kinase-3β: a novel therapeutic target for pancreatic cancer
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and is the third leading cause of adult cancer death in the United States with a single-digit 5-year survival rate despite significant advances in understanding the genetics and biology of the disease....
Gorde:
| Argitaratua izan da: | Expert Opin Ther Targets |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7539227/ https://ncbi.nlm.nih.gov/pubmed/32178549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2020.1743681 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|